drugset / Trial / NCT01512160

Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain

NCT01512160

Phase 2 Terminated 90 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the overall pain relief of a single dose of PF-04531083 against placebo following third molar extraction.

Timeline

Start
2011-10
Primary completion
2012-03
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule 400 mg
Subject PF-04531083 Small molecule 1000 mg Oral
Subject PF-04531083 Small molecule 2000 mg Oral

Indications

No indication recorded.